ArticleCurrent microbiology2026
Descriptive Epidemiological Analysis of West Nile Virus Human Infections in Italy: A Surveillance-based Study (2018-2023).
Article in Current microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
West Nile virus (WNV) is a re-emerging mosquito-borne RNA virus of the Flaviviridae family that continues to pose a significant public health threat. It is maintained in nature through a transmission cycle between wild birds, the main hosts, and vector mosquitoes, primarily Culex spp. In Italy, WNV infections have been reported since 2008, with seasonal outbreaks occurring almost annually. This surveillance-based descriptive epidemiological analysis summarizes data on confirmed human infections between 2018 and 2023, analysing annual incidence rates, 95% confidence intervals, temporal trends, and geographic distribution, while also considering environmental and demographic factors affecting transmission. During the study period, 1677 confirmed infections were reported, including 820 cases (48.9%) of West Nile neuroinvasive disease (WNND) and 116 deaths (6.9%). Annual incidence ranged from 0.095 to 0.996 cases per 100,000 population, with epidemic peaks in 2018 and 2022 and residual endemicity between 2019 and 2021. Regional clustering in the Po Valley suggests ecological suitability linked to riverine plains, agricultural zones, and climatic conditions, while temperature anomalies and rainfall patterns likely influenced mosquito dynamics and viral spread. The integration of standardized incidence rates and confidence intervals highlights the heterogeneous nature of WNV transmission across Italy. Enhanced surveillance during high-risk months (June-September), particularly in Veneto, Emilia-Romagna, and Lombardy, is crucial for timely vector control and blood donor screening. Although symptomatic cases are mandatorily reported, the true infection burden is underestimated due to undetected asymptomatic infections. Serology remains the mainstay of laboratory diagnosis, as no specific antiviral treatment or vaccine is currently available. Prevention relies on mosquito control, elimination of breeding sites, and public awareness measures aimed at reducing exposure and limiting viral transmission. The findings from this analysis can directly inform national arboviral surveillance planning, guide the timing and geographic prioritization of vector control interventions, and support evidence-based blood donor screening policies in Italy and comparable European settings.
Indexed as
Identifiers
42047874What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.